We use cookies to improve your website experience. To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy. By continuing to use the website, you consent to our use of cookies.
In Vivo is part of Pharma Intelligence UK Limited
This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.
This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183
Breathe Technologies brings in $23mm through its Series C round
27 May 2010
Executive Summary
Respiratory device company Breathe Technologies Inc. has raised $23mm through the closing of its Series C venture round. DAG Ventures led and was joined by fellow new investor Johnson & Johnson Development Corp. (both will contribute one board member) and current shareholders Kleiner Perkins Caufield & Byers, Delphi Ventures, and Synergy Partners International.
Deal Industry
Medical Devices
Medical Devices
Rehabilitation Equipment and Devices
Deal Status
Final
Deal Type
Financing
Venture Financing
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?